Firefly Neuroscience Loses $1M Financing as Securities Agreement Terminated
Summary
Firefly Neuroscience has mutually terminated a $1.0 million securities purchase agreement with an accredited investor. This agreement, originally announced on May 12, 2026, was a planned financing source for the company. The termination removes a critical near-term funding avenue, further exacerbating the company's severe liquidity issues and its previously disclosed 'going concern' warning. The company will need to secure alternative financing to continue operations.
At the time of this announcement, AIFF was trading at $1.31 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.6M. The 52-week trading range was $0.62 to $3.63. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.